NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BrainXell

BrainXell

Private
Madison, WisconsinHealthcare & Life Scienceshttps://brainxell.com/

Last Round

Grant

Aug 8, 2023

Total Funding Raised

$19.66M

Company Overview

BrainXell is a biotechnology company that manufactures customized nervous system cells derived from human stem cell lines for use in research and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

iPSC-derived neuronsiPSCscell therapydisease modelingdrug discovery toolsneuroscience researchdirected differentiationiPSC-derived gliaregenerative medicinecellular modelspatient-derived iPSCscustom cell differentiationassay servicesinduced pluripotent stem cellstoxicology screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BrainXell Comparables

Compare BrainXell with similar companies based on industry and business-model similarity.

BrainXell comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

BrainXell Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 8, 2023
Series BSep 28, 2021
AcceleratorNov 1, 2016
GrantSep 1, 2016

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 49% MoM, reaching 4K.

  • May 2, 2025

    Monthly visitors increased 35% to 2.3K.

BrainXell Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BrainXell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BrainXell's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range42
Year Founded2015
Last FundingAug 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.